TransMedics Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . TransMedics Group
TMDX Stock  USD 68.99  1.30  1.92%   
TransMedics financial statements provide useful quarterly and yearly information to potential TransMedics Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on TransMedics financial statements helps investors assess TransMedics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting TransMedics' valuation are summarized below:
Gross Profit
262.1 M
Profit Margin
0.0803
Market Capitalization
2.3 B
Enterprise Value Revenue
5.5765
Revenue
441.5 M
We have found one hundred twenty available fundamental trend indicators for TransMedics Group, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of TransMedics Group current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 2.2 B in 2025. Enterprise Value is likely to rise to about 2.3 B in 2025

TransMedics Total Revenue

463.62 Million

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 15.1 M, Selling General Administrative of 177 M or Operating Income of 39.4 M, as well as many indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0 or PTB Ratio of 9.52. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Check out the analysis of TransMedics Correlation against competitors.

TransMedics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets844.3 M804.1 M216.7 M
Slightly volatile
Total Current Liabilities62.9 M59.9 M21 M
Slightly volatile
Other Liabilities901.6 K1.4 M1.3 M
Pretty Stable
Accounts Payable6 M10.3 M5.1 M
Slightly volatile
Cash353.5 M336.6 M91 M
Slightly volatile
Other Assets748.6 K450 K735.9 K
Very volatile
Long Term Debt534.8 M509.3 M112.8 M
Slightly volatile
Inventory48.9 M46.6 M15.9 M
Slightly volatile
Total Liabilities604.2 M575.5 M148.7 M
Slightly volatile
Total Current Assets522.1 M497.2 M160.3 M
Slightly volatile
Common Stock415 M697.2 M261.7 M
Slightly volatile
Property Plant Equipment29.4 M28 M9.3 M
Slightly volatile
Other Current Liabilities47.4 M45.2 M12.5 M
Slightly volatile
Net Receivables102.6 M97.7 M20.3 M
Slightly volatile
Common Stock Shares Outstanding25.9 M35.2 M20.3 M
Slightly volatile
Short and Long Term Debt Total481.9 M458.9 M108.7 M
Slightly volatile
Property Plant And Equipment Net307.1 M292.5 M53.3 M
Slightly volatile
Current Deferred Revenue1.8 M1.7 M541.9 K
Slightly volatile
Non Current Assets Total322.2 M306.9 M56.7 M
Slightly volatile
Non Currrent Assets Other667.7 K708 K680.4 K
Very volatile
Cash And Short Term Investments175.5 M336.6 M101.5 M
Slightly volatile
Common Stock Total Equity389 M587.1 M235.3 M
Slightly volatile
Long Term Debt Total31.8 M40.5 M20.9 M
Slightly volatile
Liabilities And Stockholders Equity844.3 M804.1 M210.1 M
Slightly volatile
Non Current Liabilities Total541.3 M515.6 M209 M
Slightly volatile
Capital Surpluse158.1 M165.4 M145.9 M
Slightly volatile
Other Current Assets17.1 M16.3 M3.9 M
Slightly volatile
Property Plant And Equipment Gross349.8 M333.2 M59.8 M
Slightly volatile
Short and Long Term Debt1.4 M1.6 M1.8 M
Slightly volatile
Net Working Capital459.2 M437.3 M131.4 M
Slightly volatile
Short Term Debt2.9 M2.7 M3.7 M
Slightly volatile
Deferred Long Term Liabilities2 M1.4 M2.6 M
Slightly volatile
Capital Stock592.8 M697.2 M438.4 M
Slightly volatile
Non Current Liabilities Other6.9 M7.7 M8.4 M
Slightly volatile
Intangible Assets1.8 M2.2 M2.3 M
Slightly volatile

TransMedics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative177 M168.6 M42.1 M
Slightly volatile
Research Development29.1 M56 M23.3 M
Slightly volatile
Total Operating Expenses235.8 M224.6 M68.5 M
Slightly volatile
Interest Income15.1 M14.4 M3.6 M
Slightly volatile
Depreciation And Amortization20.7 M19.8 M3.9 M
Slightly volatile
Total Revenue463.6 M441.5 M86.5 M
Slightly volatile
Gross Profit275.2 M262.1 M51.3 M
Slightly volatile
Other Operating Expenses424.2 M404 M104 M
Slightly volatile
Cost Of Revenue188.4 M179.5 M35.1 M
Slightly volatile
Selling And Marketing Expenses2.3 M2.4 M2.7 M
Slightly volatile
Reconciled Depreciation20.7 M19.8 M3.8 M
Slightly volatile

TransMedics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings22.5 M25.8 M22.3 M
Slightly volatile
Depreciation20.7 M19.8 M3.8 M
Slightly volatile
Capital Expenditures136.2 M129.7 M29.5 M
Slightly volatile
Total Cash From Financing Activities21.7 M22.9 M75.9 M
Pretty Stable
End Period Cash Flow354 M337.1 M91.6 M
Slightly volatile
Sale Purchase Of Stock816.5 K859.5 K28.1 M
Slightly volatile
Stock Based Compensation34.9 M33.2 M6.8 M
Slightly volatile
Begin Period Cash Flow415.1 M395.3 M75.1 M
Slightly volatile
Other Non Cash Items51.2 M48.8 M8.5 M
Slightly volatile
Dividends Paid61.7 M58.8 M17.4 M
Slightly volatile
Change Receivables672 K756 K824.2 K
Slightly volatile
Cash And Cash Equivalents Changes1.4 M1.6 M1.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.464.692418.0984
Very volatile
Days Sales Outstanding69.0580.782190.6663
Slightly volatile
Stock Based Compensation To Revenue0.05780.07370.0615
Slightly volatile
Capex To Depreciation20.6919.714.5922
Slightly volatile
EV To Sales4.724.969318.3346
Very volatile
Inventory Turnover4.053.85491.3078
Slightly volatile
Days Of Inventory On Hand89.9594.6857383
Slightly volatile
Payables Turnover18.3117.43674.9896
Slightly volatile
Sales General And Administrative To Revenue0.360.38190.8288
Slightly volatile
Research And Ddevelopement To Revenue0.120.12680.8479
Slightly volatile
Capex To Revenue0.70.670.171
Slightly volatile
Cash Per Share10.6410.13095.8363
Slightly volatile
Days Payables Outstanding19.8920.9328180
Slightly volatile
Income Quality1.060.60.9489
Pretty Stable
Intangibles To Total Assets0.02060.0170.0201
Slightly volatile
Current Ratio5.668.2997.0476
Slightly volatile
Receivables Turnover4.984.51834.2152
Pretty Stable
Graham Number10.2811.5712.6118
Slightly volatile
Capex Per Share5.24.961.0278
Slightly volatile
Revenue Per Share13.9513.28743.288
Slightly volatile
Interest Debt Per Share14.9614.24394.4282
Slightly volatile
Debt To Assets0.30.57070.343
Pretty Stable
Operating Cycle167175475
Slightly volatile
Days Of Payables Outstanding19.8920.9328180
Slightly volatile
Ebt Per Ebit1.180.95421.0961
Slightly volatile
Quick Ratio5.057.52196.2959
Slightly volatile
Net Income Per E B T1.090.99121.0023
Pretty Stable
Cash Ratio5.95.6192.7297
Slightly volatile
Cash Conversion Cycle147155294
Very volatile
Days Of Inventory Outstanding89.9594.6857383
Slightly volatile
Days Of Sales Outstanding69.0580.782190.6663
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio13.9313.273.4672
Slightly volatile
Fixed Asset Turnover1.431.50983.8038
Slightly volatile
Debt Ratio0.30.57070.343
Pretty Stable
Price Sales Ratio4.464.692418.0984
Very volatile
Asset Turnover0.580.54910.2712
Slightly volatile
Gross Profit Margin0.420.59360.5445
Very volatile

TransMedics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.2 B2.1 B800.8 M
Slightly volatile
Enterprise Value2.3 B2.2 B821.7 M
Slightly volatile

TransMedics Fundamental Market Drivers

Forward Price Earnings44.6429
Cash And Short Term Investments336.6 M

TransMedics Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.7 M1.8 M
Total Revenue441.5 M463.6 M
Cost Of Revenue179.5 M188.4 M
Stock Based Compensation To Revenue 0.07  0.06 
Sales General And Administrative To Revenue 0.38  0.36 
Research And Ddevelopement To Revenue 0.13  0.12 
Capex To Revenue 0.67  0.70 
Revenue Per Share 13.29  13.95 
Ebit Per Revenue 0.08  0.09 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY